Drug-induced Pulmonary Hypertension Symposium: Applying Lessons Learned from The Aminorex Epidemic


Drug-induced Pulmonary Hypertension Symposium: Applying Lessons Learned from The Aminorex Epidemic Banner

Add to Calendar Drug-induced Pulmonary Hypertension Symposium: Applying Lessons Learned from The Aminorex Epidemic 4/13/2023 7:00:00 AM 4/14/2023 1:30:00 PM America/Los_Angeles For More Details: https://stanford.cloud-cme.com/DIPH2023 Description: Pulmonary hypertension (PH) is a rare and fatal cardiopulmonary disease that disproportionately impacts women. Despite the progress in the diagnosis, clinical care, and treatment of PH, unique etiological factors are still being discovered. Iatrogenic forms of PH are one of the leading but under-appreciated causes of the disease in the modern era. This symposium will provide expertise from the following: Stanford Universi... Hoover Institution - David & Joan Traitel Building false MM/DD/YYYY


Date & Location
Thursday, April 13, 2023, 7:00 AM - Friday, April 14, 2023, 1:30 PM, Hoover Institution - David & Joan Traitel Building, Stanford, CA

Overview
Pulmonary hypertension (PH) is a rare and fatal cardiopulmonary disease that disproportionately impacts women. Despite the progress in the diagnosis, clinical care, and treatment of PH, unique etiological factors are still being discovered. Iatrogenic forms of PH are one of the leading but under-appreciated causes of the disease in the modern era. This symposium will provide expertise from the following: Stanford University, international academic centers as well as the broader academic communities, including global organizations (World Health Organization, United States Food and Drug Administration, European Medicines Agency), and stakeholders (patients, industry partners, etc.) to develop a deeper understanding of “drug-induced pulmonary hypertension” and establish pharmacovigilance protocols for monitoring drug safety and rapid identification of PH in at-risk populations.

Registration
There are two ways to attend this hybrid activity: in-person or virtually.

1. In-Person
Registration Fees (Includes course materials, breakfast and lunch, and a certificate of participation).

Physician/AHP/RN - $399
Pulmonary Vascular Research Institute (PVRI) member from  low income countries - $299 (this registration type will be authenticated through PVRI)
Government Employee - $299
Student - $199
Industry (non-sponsor) - $1,500
Stanford Affiliate (Faculty, Staff, Students, Alumni) - $49

2. Virtually
Registration Fees (Join virtually, via Zoom. Fees include course material and a certificate of participation. You will receive your Zoom link the week of the symposium).

Physician/AHP/RN - $399
Pulmonary Vascular Research Institute (PVRI) member from low income countries - $299 (this registration type will be authenticated through PVRI)
Government Employee - $299
Student - $199
Industry (non-sponsor) - $1,500
Stanford Affiliate (Faculty, Staff, Students, Alumni) - $49


Tuition may be paid by Visa or MasterCard. Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently.

STAP-eligible employees can use STAP funds towards the registration fees for this activity.  Complete the STAP Reimbursement Request Form and submit to your department administrator. 

Credits
AMA PRA Category 1 Credits™ (12.25 hours), Non-Physician Participation Credit (12.25 hours)

Target Audience
Specialties - Critical Care & Pulmonology
Professions - Fellow/Resident, Non-Physician, Physician, Student


Objectives
At the conclusion of this activity, learners should be able to:

  1. Consider the various forms of pulmonary hypertension, based on the classifications of the World Health Organization.
  2. Develop skills/strategies to identify at risk patients for pulmonary hypertension.
  3. Identify drug classes and types linked to pulmonary arterial hypertension.
  4. Understand drug-associated mechanisms of toxicity linked to the development of pulmonary arterial hypertension.
  5. Learn pharmacovigilance methods and strategies that can help uncover existing and future pulmonary vascular related drug toxicity.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 12.25 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


Additional Information

Cancellation Policy
Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected]

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact
     Name: Melissa Schwartz
     Title: Events Project Manager
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]